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Abstract
Background: Patients with acute myocardial infarction (AMI) especially those with large MI (myocardial infarction) as
identiﬁed by ST elevation in multiple contiguous ECG leads or anterior MI, may suffer signiﬁcant myocardial damage
leading to impaired wall motion and contractility which may lead to the formation of left ventricular thrombus (LVT) in
the patient. This study was aimed to establish the incidence of LV thrombus and determine the predictors associated
with the formation of LV thrombus in patients with AMI.
Methods: This retrospective study was held at the only cardiothoracic centre of Makkah, which provides tertiary level
cardiac services. A total of 3084 consecutive patients with acute MI between 2016 and 2019 were identiﬁed and divided
into two groups i.e. group I (with LVT) and group II (without LVT). The case notes, echocardiography data and cardiac
catheterization lab records were reviewed to identify patients with LV thrombus. Regression analysis was employed to
evaluate the predictors responsible for the formation of LV thrombus.
Results: The overall incidence for LV thrombus was determined as 8.4% (n ¼ 260/3084), while in the subpopulation of
pilgrims, it was 8.2% (83/1001). Mean age for patients with and without LVT was 54 ± 11 years vs 56 ± 12 years
(p < 0.003), respectively. There was no signiﬁcant difference between the two groups with respect to gender, diabetes,
hypertension, smoking, Arabic speaking or BMI>30. Coronary thrombus aspiration was utilized in 17% vs 12%
(p < 0.023) patients with LVT and without LVT, respectively. It was observed that the patients with cardiac arrest tend to
develop more LVT i.e. 8.5% vs 5.2% (p < 0.033). However, LV thrombus formation was signiﬁcantly associated with
anterior STEMI with incidence of LVT reaching 13.4% and low ejection fraction (all MI types) i-e. 32 ± 9% vs 42 ± 11%,
with p < 0.000 for both independent predictors.
Conclusions: LV thrombus is a relatively common occurrence in patients with acute MI, especially those with anterior
STEMI and low ejection fraction<30%. Appropriate imaging studies are required for all acute MI patients in order to
ascertain the presence or absence of LV thrombus as it has major inﬂuence on further management.
Keywords: Left ventricular thrombus (LVT), ST-Elevation myocardial infarction (STEMI), Acute myocardial infarction
(AMI), Myocardial infarction (MI), Congestive heart failure (CHF), Primary percutaneous coronary intervention (PPCI),
Left main stem disease (LMSD), Triple vessel coronary artery disease (TVCAD)

1. Introduction

A

ccording to reports from the World Health
Organization (WHO), non-communicable
diseases are one of the annual major causes of

death globally. Cardiovascular diseases are the
second most common non-communicable diseases and one of the major causes of death i.e.
37% deaths caused by cardiovascular diseases in
Kingdom of Saudi Arabia [1]. The development of

Received 2 October 2020; revised 27 February 2021; accepted 2 March 2021.
Available online 30 April 2021
* Corresponding author at: Cardiac Centre, King Abdullah Medical City (in Holy Capital), Makkah Al Mukarrama, Saudi Arabia.
E-mail addresses: Niazi.A@kamc.med.sa, greatazoopk@gmail.com (A.K. Niazi).

https://doi.org/10.37616/2212-5043.1243
2212-5043/© 2021 Saudi Heart Association. This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

ORIGINAL ARTICLE

Incidence and Predictors of Left Ventricular (LV)
Thrombus after ST-Elevation Myocardial Infarction
(STEMI) in the Holy Capital of Saudi Arabia

102

JOURNAL OF THE SAUDI HEART ASSOCIATION 2021;33:101e108

ORIGINAL ARTICLE

left ventricular thrombus (LVT) is a recognized
complication in a variety of cardiac conditions
and the highest rate is observed in acute
myocardial infarction (AMI) and congestive heart
failure (CHF) secondary to severe left ventricular
systolic dysfunction [2, 3] (Figs. 1e3). If formation
of LV thrombus leads to cerebrovascular events,
then it is a severe and potentially fatal complication especially following ST-segment elevation
myocardial infarction (STEMI). Mortality from
acute myocardial infarction has decreased markedly since the beginning of primary percutaneous
coronary intervention (PPCI) which has proven to
be more effective than thrombolytic therapy by
showing less mortality rates and lesser clinical
adverse events. However, post-infarct complications still lead to morbidity and mortality in a
large number of patients. The risk of LV
thrombus formation is at its peak during the ﬁrst
3 months following acute myocardial infarction.
The incidence of LV thrombus has been reported
to be in the range of 2.9%e15% in western regions
[4]. Initial diagnostic modality was conducted
using transthoracic echocardiography (TTE), but
advances in non-invasive imaging techniques
(contrast echocardiography, cardiac CT and cardiac MRI) have improved the sensitivity for
diagnosis of LV thrombus. Once diagnosed, the
initial management is anticoagulation with
warfarin [5]. The prevalence of LV thrombus
especially in primary PCI era is apparently
reducing with the estimated prevalence rate
ranging between 5% and 15% [6,7,9].

Fig. 1. LV Thrombus demonstrated by Transthoracic Echocardiography.

Fig. 2. LV Thrombus demonstrated by Echocardiography with IV
contrast agents.

There is limited data available on the exact frequency of LV thrombus in primary PCI treated
acute MI patients in Saudi Arabia. In the current
retrospective study, we reviewed the incidence of
LV thrombus and its associated risk factors in patients presented with acute myocardial infarction
who were referred to King Abdullah Medical City
(KAMC) Makkah. Because it is located at the holy
capital Makkah, we had an opportunity to study the
diverse but vulnerable, subpopulation of pilgrims in
order to establish the incidence of LV thrombus in
addition to the general population. The main
objective of current study was to identify predictors
so as to establish a strategy for vigilant surveillance
of vulnerable groups with repeated screening for LV
thrombus and its timely treatment.

Fig. 3. LV Thrombus demonstrated by Cardiac MRI.

2. Material and Methods
This retrospective study was held at the only public
sector cardiothoracic centre of the Holy Makkah region which provided tertiary level cardiac services. A
total of 3084 consecutive acute MI patients were
identiﬁed during the period from 2016 to 2019.
2.1. Data Collection
The acute myocardial infarction patients are
referred to this centre for further management. The
patient's data comprised of those who sustained
myocardial infarction and were brought for either
primary PCI, post thrombolysis routine PCI (within
1 week of thrombolysis) or late presenter MI, i-e.
those patients who presented more than 12 h after
onset of symptoms and did not receive any reperfusion therapy. All patients did transthoracic echocardiography within 24e48 h up to 1 week during
admission. The echocardiographic ﬁnding of LV
thrombus refers to this initial echocardiogram conducted during the period of admission.
Demographic, clinical outcomes and echocardiographic data were obtained from the electronic and
medical records. Patients with diabetes, hypertension or known smokers were identiﬁed from history
and case notes. Anterior STEMI was deﬁned as ST
segment elevation in precordial leads on initial ECG
(electrocardiogram). Left ventricular function was
assessed using Simpson's method and 16-segment
model was used to score the severity of wall motion
abnormality by transthoracic echocardiography.
The presence of LV thrombus was evaluated in
apical 2 and 4 chamber views and off axis views. LV
thrombus was classiﬁed into deﬁnite or probable
types. Deﬁnite LV thrombus was deﬁned as a
discrete echodense mass in the left ventricular
distinct from the endocardium and adjacent to an
area of hypokinetic or akinetic myocardium. Probable thrombus was suspected when the images were
technically challenging and an echodense mass
could not be excluded. For probable thrombus patients, IV contrast echocardiography, cardiac CT or
cardiac MRI were assigned and cases were identiﬁed as “with LVT” or “without LVT”. (The numeric
data is not included in analysis for simpliﬁcation of
study). Coronary angiography, angioplasty and
coronary thrombus aspiration were performed by
interventional cardiologists as per standard protocols. The cardiac catheterization procedure logs
and reports were reviewed for procedural ﬁndings
and date of procedure. Anticoagulation therapy was
initiated by the use of unfractionated heparin or low
molecular weight heparin along with warfarin for
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therapeutic anticoagulation to achieve the target
INR range of 2e3.
2.2. Statistical Analysis
The statistical analysis was performed using SPSS
version 20. Data were presented as mean, standard
deviation for continuous data and percentages for
categorical variables. Baseline and in-hospital characteristics were compared in both groups according
to the echocardiographic ﬁndings. Univariate analysis was done using t-test and chi-squared test for
continuous and categorical variables, respectively. A
p value<0.05 was considered signiﬁcant. Regression
analysis was applied to determine the predictors for
the formation of LV thrombus. Variables with p
values < 0.1 were retained in the multivariable model.

3. Results
3.1. Key Results
A total of 3084 consecutive patients who met the
criteria were included in the analysis. The LV
thrombus was detected in 8.4% patients in general,
whereas in sub population of pilgrims, the incidence
of LV thrombus was established as 8.2%. Anterior
STEMI and poor ejection fraction<30 were recognized as independent and signiﬁcant predictors
associated with the formation of LV thrombus.
3.2. Demographics
Other than age (p < 0.003), gender, diabetes, hypertension and smoking were found to be statistically non-signiﬁcant in both groups. The incidence
of LV thrombus in males turned out to be 9% vs
6.2% in female population (p < 0.05). There was no
major difference of incidence between general
population vs pilgrims i.e.8.2% vs 8.4%. However, it
was slightly higher in non-Arabic speakers vs
Arabic speakers i.e. 9.3% vs 7.9%. There were no
pre-hospital clinical characteristics that differed
among the groups. Baseline characteristics in patients with LVT and without LVT are shown in Table
1.
3.3. Infarct Related Characteristics
The prevalence of anterior STEMI for group I and
group II was 86.6% vs 52.1% (p < 0.001), respectively.
Incidence of LV thrombus in patients with anterior
STEMI was ascertained as 13.4% (p < 0.001).
Signiﬁcantly lower mean LV ejection fraction such
as 32 ± 9% vs 42 ± 11% was observed (p < 0.001) for
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Table 1. Baseline clinical characteristics, Infarct related characteristics and Procedure related data in patients With and Without LV Thrombus.
Variables
Age years
Mean ± SD
Gender male
Arabic speaking
Pilgrims
Co-morbidities
DM
HTN
Smoking
BMI <30
Infarct Related Characteristics
Thrombolysis
Late presenting STEMI
Anterior
2ndmax Trop
Mean ± SD
Procedural Data
Trans radial
LMS
TVCAD
Tiroﬁban
Aspiration
Number of stents
Mean ± SD

With LVT
n ¼ 260

Without LVT
n ¼ 2824

p-value

54 ± 11
229 (88%)
102 (57.3%)
83 (32.2%)

56 ± 12
2338 (84%)
1183 (62%)
918 (33.2%)

<0.003
<0.053
0.260
0.403

146 (56.2%)
137 (52.7%)
89 (34.2%)
72 (27.8%)

1517 (54.1%)
1498 (53.5%)
922 (33%)
790 (29%)

0.289
0.431
0.679
0.399

53 (20.4%)
29 (11.2%)
222 (86%)
115 ± 199

512 (18.3%)
345 (12.3%)
1435 (52.1%)
94 ± 230

NS
NS
<0.001
NS

212 (81.5%)
10 (3.9%)
39 (15.1%)
69 (26.6%)
44 (17%)
1.2 ± 0.8

2149 (76.6%)
79 (2.9%)
437 (15.8%)
677 (24.3%)
333 (12%)
1.3 ± 0.8

NS
NS
NS
NS
NS
NS

LVT ¼ left ventricular thrombus, SD ¼ standard deviation, NS ¼ non signiﬁcant, DM ¼ diabetes mellitus, HTN ¼ hypertension,
BMI ¼ body mass index, STEMI¼ ST-elevation myocardial infarction, Trop ¼ Troponin, LMS ¼ left main stem, TVCAD ¼ triple vessel
coronary artery disease.

group I as compared to group II, respectively. In a
subpopulation of patients with anterior MI and poor
EF which comprises of 60% of anterior MI patients,
we found out that 25.6% had developed LVT.
The mean value of 2nd maximum troponin I
(signifying larger infarct size) was found to be
slightly higher in patients with LVT compared to
those without LVT (i.e. 115 ± 199 vs 94 ± 230,
p < 0.184). Categorical analysis for both groups is
shown in Table 1.
3.4. Procedural Characteristics
Transradial approach was the preferred approach
for PCI in patients with LV thrombus i.e. 82%
(p < 0.080). Incidence of LVT in tiroﬁban administered patients was 9.2%.Use of thrombus aspiration
was noticed to be signiﬁcantly higher in patients
with LVT i.e. 17% vs 13% in those without LVT
(p < 0.023). No signiﬁcant association of LV
thrombus was documented with mean value of
number of stents, left main stem disease and triple
vessel coronary artery disease (Table 1).

cardiovascular events (MACE) deﬁned as a combination of cardiogenic shock, pulmonary oedema,
intubation ventilation and cardiac arrest during inhospital stay i-e. 13.4% vs 8.1%, p value < 0.005. To
this end, a trend towards signiﬁcance was observed
in post procedural immediate in-hospital clinical
outcomes, including cardiogenic shock, intubation
ventilation and cardiac arrest. Patients with LV
thrombus tend to have higher percentage of occurrence of cardiogenic shock i.e. 7% vs 4% (p < 0.036),
pulmonary oedema 4.6% vs 3.4% (p < 0.290), intubation ventilation 7.3% vs 4% (p < 0.151) and cardiac
arrest 8.5% vs 5.2% (p < 0.033). Length of stay was

Table 2. In-hospital outcome parameters.
Variables

With LVT
n ¼ 260

Without LVT
n ¼ 2824

p value

12
18
19
22

95 (3.4%)
113 (4.0%)
127 (4.5%)
146 (5.2%)

NS
<0.036
NS
<0.033

3.5. Outcomes Characteristics

Pulmonary oedema
Cardiogenic shock
Intubated ventilated
Cardiac arrest
Post PCI EF(%)
Mean ± SD
Length of stay (days)
Mean ± SD

42 ± 11
5.4 ± 8

<0.001
<0.001

There was a strong correlation of LV thrombus
and the composite end point for major adverse

LVT ¼ left ventricular thrombus, NS ¼ non-signiﬁcant, Post PCI
EF ¼ post percutaneous coronary intervention ejection fraction,
SD ¼ standard deviation.

(4.6%)
(6.9%)
(7.3%)
(8.4%)

32 ± 9
8±7

Table 3. Independent predictors for LV Thrombus
Formation.
Variables

p value

Post PCI_EF
Anterior STEMI

<0.001
<0.001

evaluated to be signiﬁcantly higher in patients with
LVT i-e. 8±7 vs 5.4 ± 8 (p < 0.000) (Table 2).
3.6. Multivariate Logistical Regression Model
Regression analysis was performed to assess the
formation of LV thrombus by independent predictors. After adjusting for diabetes mellitus,
thrombolysis, late presenters and pilgrims, the
clinical predictors for an increased risk of LV
thrombus formation were recognized as poor
EF<30% and anterior STEMI (p < 0.000) (Tables 3
and 4).

4. Discussion
The formation of left ventricular thrombus is a
dreaded post myocardial infarction complication
leading to high risk of thromboembolism especially
cerebrovascular accidents [10]. The Virchow's triad
is thought to be the main stay of pathogenesis
behind formation of LV thrombus. This includes a
vicious cycle starting after the combination of blood
stasis, which is secondary to LV regional wall akinesia or dyskinesia along with subendocardial
damage from prolonged ischemia and a hypercoagulable state which is a main factor of atherosclerosis [8].
Regional data regarding incidence of LVT formation following acute MI in the era of primary
PCI is yet to be established. The prime objectives of
this study were to identify the incidence and predictors for LV thrombus formation in patients with
acute myocardial infarction. Current study which is
part of an ongoing project also aimed to support
the establishment of practical guidelines for

repeated screening of high-risk cases, utilizing serial echocardiography in post MI patients. The
overall incidence of LV thrombus in the current
study was 8.4%. Earlier studies from the prethrombolytic and thrombolytic eras suggested that
LV thrombus had been present in up to 46% of
acute MI patients [11]. In the present era, incidence
of LV thrombus formation following acute MI is
thought to be lower (5%e10%) owing to the widespread use of rapid mechanical reperfusion and
potent anti-platelet and anti-thrombotic agents
[8,12].
It is worth mentioning that while being located at
the holy city of Makkah, pilgrims formed an integral
part of our patient's population. The pilgrims are a
vulnerable group comprising of participants from
all over the world with different risk proﬁles. They
perform religious rituals in highly stressful conditions and in a mass gathering of millions. Yet no
speciﬁc studies had been carried out in the past to
establish the incidence of LV thrombus in this
diversiﬁed population of pilgrims of Makkah.
Regarding our study, the incidence of LVT in pilgrims was determined as 8.2% which was almost
similar to the overall incidence in the general population i.e. 8.4%.
Regarding incidence of LV thrombus, our results
are in accordance with a recent study from Austin
et al. where from an initial yield of 1144 studies,
inclusion criteria was met by 19 studies including
10,076 patients across 27 centres in 9 countries. Rate
of LV thrombi after all STEMI was 2.7% and 9.1%
after anterior STEMI. Current study provided data
of regional incidence for LVT based on the reality
that although, primary PCI is considered the
preferred method of revascularization in patients
with myocardial infarction which leads to better
salvage of the myocardium [12], there is however,
limited data on the incidence of LVT in patients with
myocardial infarction in the primary PCI era [14,15].
This study shows higher incidence than Zielinska
et al. which diagnosed LV thrombus in 5.4% of acute

Table 4. Detailed regression analysis.
Variable

B

S.E.

Wald

df

Sig.

Exp(B)

95% C.I.forExp(B)
Lower

Upper

Step 1a Age
PostPCI_EF
ANT_STEMI (1)
Cardiogenic Shock (1)
MPV
HbA1C
Constant

0.023
0.058
1.471
0.019
0.022
0.006
0.275

0.007
0.008
0.225
0.364
0.041
0.026
0.697

11.596
56.992
42.890
0.003
0.286
0.052
0.156

1
1
1
1
1
1
1

0.001
0.000
0.000
0.958
0.593
0.820
0.693

0.977
0.943
4.356
0.981
1.022
1.006
0.759

0.964
0.929
2.804
0.481
0.944
0.956

0.990
0.958
6.766
2.001
1.107
1.059

Post PCI EF ¼ post percutaneous coronary intervention ejection fraction, STEMI¼ST-elevation myocardial infarction.
a
Variable(s) entered on step 1: Age, PostPCI_EF, ANT_STEMI, CardiogenicShock, MPV, HbA1C.

ORIGINAL ARTICLE

105

JOURNAL OF THE SAUDI HEART ASSOCIATION 2021;33:101e108

106

JOURNAL OF THE SAUDI HEART ASSOCIATION 2021;33:101e108

ORIGINAL ARTICLE

anterior wall MI patients and only 0.3% LV
thrombus was diagnosed in non-anterior wall
myocardial infarctions, whereas our study shows
that the LV thrombus was diagnosed in 13.4% of
patients with anterior MI [16].
The percentage of primary PCI was 71% of the
patients with Solheim et al. whereas in the current
study, PPCI was done in 80% (207/260) of LVT
patients [17]. Similar results have been reported in
a study that early LV thrombi were detected in
7.1% (21/297) acute anterior MI patients who had
been treated with primary PCI [15]. One of the
aspects of our study is that the incidence of LV
thrombus did not vary signiﬁcantly between patients treated with primary PCI, thrombolysis or
conservatively, which is also endorsed by Solheim
et al. Larger infarcts (depicted by higher 2nd
Troponin I) are associated with more pronounced
myocardial injuries, an increased inﬂammatory
response, extensive wall motion abnormalities and
a hypercoagulable state, thereby imposing an
increased risk for the formation of mural thrombus
[17,20,21].
In accordance with our results, Osherov et al. also
found no difference in the frequency of LVT in patients treated with thrombolysis compared to primary PCI [16]. Similarly, Zielinska et al. also could
not prove any inﬂuence of the use of glycoprotein
IIb/IIIa receptor blockers on the occurrence of mural
thrombosis [16,17]. Similarly, Adam et al. identiﬁed
cardiac arrest as a clinical characteristic independently associated with the development of LV
thrombus. The patients with cardiac arrest may
have larger infarcts due to proximal vessel location,
lack of preconditioning or potentiation of transmural injury due to hypotension. In addition, the
transient stasis of blood associated with cardiac arrest may also predispose patients to thrombosis in
the arterial system [22,23].
The current study also detected poor ejection
fraction <30% and anterior wall MI as a strong
predictor of LVT similar to those studies, stating that
larger infarcts are associated with more marked
myocardial injuries, extensive wall motion abnormalities and a hypercoagulable state so that there is
an increased risk for the formation of mural
thrombus [12,13,18,19]. Our observation suggests
that such patients are a potential risk group for
cardio-embolic complications in the primary PCI
era [22]. In a similar study by Khouri et al. LVT was
diagnosed in second echocardiography and in patients with reduced ejection fraction, 40% had a
repeat test before hospital discharge (days 5e7) [24].
This strategy needs more attention and testing in
our centre.

5. Study Limitations
We acknowledge the limitations of this retrospective study regarding selection bias especially referral
bias because data comprised of acute myocardial
infarction patients who were referred to this cardiac
centre for further management. Patients were mainly
diagnosed with transthoracic echocardiography, but
some cases were also conﬁrmed by IV contrast
echocardiography, cardiac CT or cardiac MRI.The
data is not comprehensive, therefore, further analysis
is required. Another limitation might be the lack of
more frequent echocardiographic examinations,
including pre-discharge echo (24 h, 5e7 days, and 1
month after acute MI) which may miss about 15%e
30% of late LV thrombus formation, occurring at 1e3
months after onset of acute MI [4]. Further studies are
required for the use of anticoagulation and outcomes
in patients with LV thrombus.
5.1. Suggestions
Delayed LV thrombus formation in patients with
myocardial infarction has been demonstrated when
echocardiography is performed just prior to
discharge or 1e3 months after discharge, so the
diagnosis of LV thrombus should be considered
during follow-up visits as well. Although, current
guidelines state that the need for serial echocardiography in patients with acute myocardial infarction
still remains controversial. Routine use of contrast
echocardiography in severely reduced ejection
fraction may lead to more frequent diagnosis of LV
thrombus cases.
5.2. Beneﬁts of this Study/What Does This Study
Add to What We Already Know?
First, this study corroborates earlier studies by
conﬁrming that the LV thrombus is still a wellknown complication in patients with myocardial
infarction, despite the use of mechanical reperfusion
therapy, potent anti-platelet and antithrombotic
therapy. The predictors include poor ejection fraction and anterior STEMI so serial echocardiographic
examination is recommended in such cases especially for the diagnosis of LV thrombus cases.
Finally, this study draws attention towards the fact
that LV thrombus remains an important complication of myocardial infarction in the contemporary
era. In order to prevent potentially devastating
thromboembolic complications, this study reminds
us to remain vigilant and actively seek LV
thrombus, particularly in high risk patients presenting with STEMI prior to hospital discharge.
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